Tag: Disease progression

Browse exclusive Tags!

Selpercatinib Outperforms Competitors in Treating RET-Mutant Thyroid Cancer, France

Discover the promising results of selpercatinib, a kinase inhibitor by Eli Lilly, in treating RET-mutant medullary thyroid cancer. Outperforms competitors with improved outcomes and longer progression-free survival.

Sleep Disturbances in Huntington’s Disease: Impact on Disease Outcomes

Discover the impact of sleep disturbances on Huntington's Disease outcomes. Learn how addressing sleep dysfunction can improve quality of life.

Lilly’s Alzheimer’s drug shows 60% decrease in mild impairment during clinical trial

Lilly's Donanemab Slows Alzheimer's by 60% in Early Stages

Intense Exercise May Slow Parkinson’s Disease Progression

Discover the groundbreaking findings on how intense exercise could slow down the progression of Parkinson's disease. Learn about the neuroprotective effects and potential non-drug therapeutic targets.

Popular

Lilly’s Alzheimer’s drug shows 60% decrease in mild impairment during clinical trial

Lilly's Donanemab Slows Alzheimer's by 60% in Early Stages

Intense Exercise May Slow Parkinson’s Disease Progression

Discover the groundbreaking findings on how intense exercise could slow down the progression of Parkinson's disease. Learn about the neuroprotective effects and potential non-drug therapeutic targets.

Selpercatinib Outperforms Competitors in Treating RET-Mutant Thyroid Cancer, France

Discover the promising results of selpercatinib, a kinase inhibitor by Eli Lilly, in treating RET-mutant medullary thyroid cancer. Outperforms competitors with improved outcomes and longer progression-free survival.

Sleep Disturbances in Huntington’s Disease: Impact on Disease Outcomes

Discover the impact of sleep disturbances on Huntington's Disease outcomes. Learn how addressing sleep dysfunction can improve quality of life.

Subscribe

spot_imgspot_img